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PURPOSE. Migraine, particularly with aura, has been associated with ocular and systemic
ischemic complications, but there are limited data on the ocular vasculature in migraine. We
used optical coherence tomography angiography (OCTA) to assess perfusion of the macula
and optic nerve in migraine patients, with (MA) and without (MO) aura, compared to healthy
controls (HC).
METHODS. We recruited 15 MA (mean age 42 years), 12 MO (mean age 46 years), and 22 HC
(mean age 39 years) participants from neurology and neuro-ophthalmology clinics. Participants
underwent optical coherence tomography and 3 3 3 mm OCTA of the macula and optic
nerve. Foveal avascular zone area was automatically measured using AngioVue software, and
vessel density was calculated as blood vessel length divided by scan area (mm1) after
skeletonization of OCTA images.
RESULTS. On macular OCTA, MA participants had an enlarged foveal avascular zone area when
compared with HC (0.300 6 0.019 vs. 0.220 6 0.066 mm2, P ¼ 0.006). In addition,
superficial foveal vessel density was decreased in MA participants when compared with MO
participants (7.8 6 0.31 vs. 9.3 6 0.44, P ¼ 0.04) and HC (7.8 6 0.31 vs. 9.4 6 0.21 mm1,
P ¼ 0.002). On optic nerve OCTA, the MA participants had reduced superior peripapillary
vessel density when compared with the MO participants (12.0 6 0.45 vs. 14.0 6 0.38 mm1,
P ¼ 0.031) and HC (12.0 6 0.45 vs. 14.1 6 0.53 mm1, P ¼ 0.035). There were no
significant differences between the MO and HC groups.
CONCLUSIONS. Migraine with, but not without, aura was associated with foveal and
peripapillary vascular decrements, which may possibly mediate increased risk of ocular and
systemic vascular complications in these patients. OCTA could potentially be useful as a
biomarker for migraine with aura.
Keywords: migraine, OCT angiography, neuro-ophthalmology
Migraine is the third most common disease worldwide, withan overall prevalence of 14.7% (18.8% in females and
10.7% in males).1 In one third of patients, migraine headaches
are preceded by focal neurological disturbances, typically
visual, which are termed ‘‘migraine auras.’’2 The pathophysiol-
ogy of migraine is not fully elucidated, but a complex interplay
of neural and vascular factors is likely involved.3 Migraine has
been suggested as a risk factor for ischemic complications of
the retina and optic nerve,4–9 in addition to systemic ischemic
events including stroke and myocardial infarction.10,11 The
associations are stronger for migraine with aura (MA) than
migraine without aura (MO).10,12
Ophthalmic disorders associated with migraine include
branch and central retinal artery and vein occlusions4–7 as well
as anterior and posterior ischemic optic neuropathy.8,9,13–16 In
addition, migraine has been reported to be a risk factor for
diagnosis and progression of normal tension glaucoma.17,18
These disorders have been reported both during an acute
attack of migraine4,7–9 as well as between attacks.5,15,17 Thus,
there may be both acute and chronic changes of ocular
perfusion in migraine patients that predispose migraineurs to
the ocular complications previously described.
Despite this, there are limited data on the ocular
vasculature in migraine patients. Rose et al.19 examined the
retinal microvasculature in subjects with migraines using
fundus photography and reported a higher incidence of
retinopathy in migraine patients when compared with
controls. Limitations of fundus photography include relatively
low-resolution and poor visualization of deeper ocular
vasculature including the deep capillary plexus and choroid.
Recently, optical coherence tomography angiography (OCTA)
has been developed and applied to imaging the microvascu-
lature of both the macula and optic nerve.20,21 OCTA uses
phase or amplitude decorrelation technology to image the
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ophthalmic vasculature at a resolution of 5 lm in three
dimensions, allowing for segmentation with separate analysis
of superficial and deep capillary networks.
We examined the macular and optic nerve vasculature in
patients with migraine, with and without aura, using OCTA,
and compared the findings with healthy controls. In addition,
we evaluated the structural parameters of the macula and optic
nerve using spectral-domain optical coherence tomography
(OCT). Because of the potential risk of systemic and ocular
ischemic events in migraine patients, especially those with
aura, we hypothesized that the eyes of these patients would
have an increased foveal avascular zone (FAZ) area when
compared with controls. In addition, we hypothesized that
migraine patients would have decreased vessel density (VD) in
the macula and optic nerve as well as decreased foveal,
ganglion cell complex (GCC), and retinal nerve fiber layer
(RNFL) thickness.
METHODS
This study was approved by the University of California, Los
Angeles Institutional Review Board and adhered to the tenets
of the Declaration of Helsinki and Health Insurance Portability
and Accountability Act. Informed consent was obtained from
all participants after explanations of the nature and possible
consequences of the study. We prospectively recruited
patients diagnosed with migraine, with and without aura,
from neurology and ophthalmology clinics. Healthy controls
(HC) were recruited from ophthalmology clinics and among
faculty and staff members at the University of California, Los
Angeles. All participants were 18 years of age or older.
Participants with migraine met the International Classification
of Headache Disorders 3 criteria for diagnosis of migraine
with aura (MA) or migraine without aura (MO),22 and most
were under the care of a neurologist specializing in headache
disorders (MJ, AC). HC reported either no headaches or
headaches not meeting the International Classification of
Headache Disorders 3 criteria for migraines.22 In particular,
healthy controls who experienced any headaches were
required to have the absence of all of the following
International Classification of Headache Disorders 3 charac-
teristics of migraines: moderate or severe pain intensity,
aggravation by or causing avoidance of routine physical
activity, nausea, vomiting, photophobia, and phonophobia.
Exclusion criteria for all groups included any neurologic
disorder other than migraine (including neurodegenerative
diseases such as Alzheimer’s or Parkinson’s diseases); any
disorder of the optic nerve (including glaucoma) or retina;
history of intraocular surgery other than cataract extraction,
refractive error greater thanþ3.00 or less than6.00 diopters;
systemic conditions affecting microvasculature such as
diabetes mellitus, hypertension, vasculitis, or renal disease;
and ocular media opacity precluding high-quality imaging.
Healthy controls were also excluded if taking vasoactive
medications such as calcium channel blockers. Demographic
data for 15 MA, 12 MO, and 22 HC participants who met
inclusion and exclusion criteria are shown in Table 1.
Ophthalmologic Examination
All participants underwent full ophthalmologic examination of
each eye by a neuro-ophthalmologist (MYC, ACA) or retina
specialist (DS), including best-corrected visual acuity, refractive
error based on manifest refraction (if visual acuity was worse
than 20/20), or habitual glasses prescription, IOP (measured by
iCare tonometer [Finland Oy, Vantaa, Finland] or Goldmann
applanation [Haag-Streit, Koniz, Switzerland], depending on
instrument availability), pupil size and reactivity, color vision
testing by Ishihara plates, visual fields by confrontation,
extraocular motility and alignment, slit lamp examination,
and fundus examination of the posterior pole.
Acquisition of Images
All participants underwent OCT and OCTA imaging using the
RTVue XR Avanti spectral-domain OCT device with AngioVue
software (Optovue, Inc., Fremont, CA, USA). This instrument
uses a light source at 840 nm with a bandwidth of 45 nm and A-
scan rate of 70,000 scans per second. OCT and OCTA images
were excluded if the signal strength index was less than 45 or if
the automated algorithm failed to correctly segment the image.
OCT Angiography Scans. OCTA images of the macula and
optic nerve were both acquired in a 3 3 3 mm cube, each
containing 3043304 scans. Two scans, one horizontal and one
vertical, were obtained and merged to minimize motion
artifact. Split-spectrum amplitude decorrelation technology
was used to improve the signal-to-noise ratio.
Structural OCT Scans. The macula was imaged using the
macula line protocol, consisting of a 9.0-mm b-scan centered
on the fovea generated by averaging 65 frames. A 6.036.0 mm
volume scan of the optic nerve was generated using the three-
dimensional (3D) disc protocol, which was used as a baseline
for RNFL. The peripapillary RNFL was imaged using the optic
nerve head (ONH) protocol, which evaluated RNFL thickness
along a 3.45-mm diameter circle centered on the optic nerve
head. The GCC, which includes the RNFL, ganglion cell layer,
and inner plexiform layer, was imaged in a 6.0 3 6.0 mm
circular area in the macula using the GCC scan protocol.
Analysis of Images
OCT Angiography Scans. Each scan was automatically
segmented by the AngioVue software (Fig. 1). In the case of
macular scans, the superficial retinal capillary plexus (SCP)
was segmented with an inner boundary 3 lm posterior to the
internal limiting membrane (ILM) and outer boundary 15 lm
posterior to the outer aspect of the inner plexiform layer (IPL;
Fig. 1A). The deep retinal capillary plexus (DCP) was
segmented with an inner boundary 15 lm posterior to the
outer aspect of the IPL and outer boundary 70 lm posterior to
the outer aspect of the IPL (Fig. 1B). Optic nerve scans were
segmented into ONH and radial peripapillary capillary (RPC)
TABLE 1. Demographics and Clinical Data
Demographic and Clinical Measures MA, n ¼ 15 MO, n ¼ 12 HC, n ¼ 22
Mean age in years (range) 42 (18 to 64) 46 (29 to 58) 39 (18 to 66)
Male/female 5/10 3/9 14/8; *P ¼ 0.03
Mean refractive error, SE (range) 0.50 (5.25 to þ0.75) 0.50 (2.25 to þ1.75) 1.25 (4.25 to plano)
Mean IOP, mm Hg (range) 16 (12 to 21) 13 (9 to 20) 16 (13 to 19)
MA, migraine with aura; MO, migraine without aura; HC, healthy controls; SE, spherical equivalent; IOP, intraocular pressure.
* P < 0.05, controls versus MO.
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slabs. The ONH slab was segmented with an inner boundary at
the anterior border of the ILM and an outer boundary 150 lm
posterior to the ILM (Fig. 1C). The RPC slab was delimited with
an inner boundary at the ILM and an outer boundary at the
posterior aspect of the RNFL (Fig. 1D). The ONH slab was used
to measure whole-image and ONH VD, whereas the RPC slab
was used to measure peripapillary VD.
The following measures were extracted from en face
OCTA images of the macula: FAZ area and VD in the SCP and
DCP. The FAZ area was measured using AngioVue software
using a slab from the internal limiting membrane (ILM) to 75
lm above the retinal pigment epithelium. Although prior
OCTA studies reported the FAZ area separately for the SCP
and DCP, more recent histologic and OCTA data suggest that a
single merged quantitative measurement is more accurate
because of the convergence of the SCP and DCP in the
parafoveal region.23 Quantitative analysis of VD in the SCP
and DCP was performed as previously described by Iafe and
colleages.20 Briefly, the OCTA en face images were exported
and raw images were imported into ImageJ24 (provided in the
public domain by the U.S. National Institutes of Health,
Rockville, MD, USA). The images were then made binary and
skeletonized, converting each blood vessel to a one-pixel
wide line. The number of black pixels representing blood
vessels was extracted using histogram analysis. Vessel density
was calculated as: [(pixels of blood vessels)3 (scan width in
mm/pixels per scan width)]/area in mm2, resulting in a
density with a unit of mm1. The VD was calculated in the
whole 333 mm image (Fig. 2A,B) as well as a 131 mm circle
centered on the fovea (Fig. 2C).
En face OCTA images of the optic nerve in the ONH and
RPC segments were similarly exported and analyzed using
ImageJ (Fig. 3). The whole-image VD was assessed using the
ONH segment (Fig. 3B). A scanning laser ophthalmoscope
image acquired at the time of OCTA was superimposed on the
skeletonized OCTA image to outline the borders of the ONH
(Fig. 3C). VD within the borders of the ONH was then
calculated (Fig. 3D). The RPC image was processed in the same
manner (Figs. 3E–H). Peripapillary VD was assessed in a ring
measuring 0.5 mm in width encircling the optic nerve head on
the RPC segment of the OCTA. The peripapillary ring was
divided into superior and inferior halves, and the VD was
separately analyzed in these two hemispheres.
In addition to angiography images, the Optovue software
automatically measures retinal thickness from the macular
OCTA scans. The foveal thickness of each eye, measured at the
center of the fovea and spanning the entire retina, from the
ILM to retinal pigment epithelium was recorded.
Structural OCT Scans. Structural OCT scans of the
macula and optic nerve were reviewed by an ophthalmologist
(MYC) to exclude the possibility of retinal or optic nerve
pathology, including glaucoma. Any macular pathology, such
as drusen or epiretinal membrane, resulted in exclusion of the
affected eye from the study. Glaucoma was defined as IOP
greater than 21 mm Hg with characteristic glaucomatous
optic nerve cupping on examination and/or RNFL thinning on
OCT. Eyes with any optic nerve pathology including glaucoma
were excluded.
The following measurements were recorded from the OCT
RNFL scans for each eye: average RNFL thickness and thickness
in each quadrant (superior, temporal, inferior, and nasal). The
average, superior, and inferior GCC thickness measurements
were also recorded.
Power Calculation. Based on the first five participants in
each group who underwent OCTA scans, a power calculation
FIGURE 1. En face OCTA scans with the corresponding b-scan OCT
shown immediately below. The level of segmentation is between the
red and/or green lines on the OCT. (A) Superficial retinal capillary
plexus, (B) deep retinal capillary plexus, (C) ONH slab, (D) RPC slab.
FIGURE 2. Processing of macular OCTA scans for measurement of VD. (A) Raw image of macular OCTA scan of the SCP. (B) The raw image was
made binary and skeletonized for calculation of whole image vessel density. (C) A 13 1 mm circular area centered on the fovea was selected for
measurement of foveal VD.
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was performed to determine the number of participants
required to detect a significant difference in foveal avascular
zone area, the primary outcome in this study. We found that 14
participants would be required in each group to detect a
difference of 0.1 mm2 with a type I error (a) of 0.05 and a type
II error (b) of 0.20.
Statistical Analysis
OCT and OCTA measurements of the optic nerve and retina
were compared between MA, MO, and control participants
using 2-way repeated measures analysis of variance to account
for inclusion of both eyes per participant. Subgroup analysis was
performed by gender; female participants were compared with
female controls, and male participants were compared with
male controls. P values less than 0.05 were considered
significant.
RESULTS
We recruited 15 MA, 12 MO, and 22 healthy control
participants. The mean ages for the MA, MO, and HC
participants were 42, 46, and 39 years, respectively, and did
not significantly differ among groups (P > 0.08; Table 1). There
were significantly more males in the control group when
compared with the MO group (P¼ 0.03). The mean refractive
error and intraocular pressure were not significantly different
among the groups (P > 0.05). All macular OCTA images except
one were of sufficient quality for study inclusion. Five optic
nerve OCTA images were excluded because of poor quality
(signal strength index less than 45), and two optic nerve OCTA
scans were excluded as a result of the failure of the automated
segmentation algorithm.
Representative OCTA scans of the MA, MO, and HC
participants are shown in Figures 4 (macula) and 5 (optic
nerve). Quantitative analysis of macular OCTA findings in the
MA, MO, and HC participants is shown in Table 2. The FAZ area
measured 0.300 6 0.019 mm2 in the MA participants,
significantly larger than the control participants (0.220 6
0.066 mm2, P ¼ 0.006). In addition, the foveal VD in the SCP
was significantly lower in the MA participants (7.8 6 0.31
mm1) when compared with both the MO (9.3 6 0.44, P ¼
0.04) and control (9.4 6 0.21, P ¼ 0.002) participants. There
were no significant differences between the MO and control
participants. In addition, there was no significant difference
among the MA, MO, and control participants in whole-image
VD in the macula in the SCP or any measure in the DCP (P >
0.09).
The optic nerve OCTA measurements in the MA, MO, and
HC participants are displayed in Table 3. The superior
peripapillary VD was significantly reduced in the MA
participants (12.0 6 0.45 mm1) when compared with both
the MO (14.0 6 0.38 mm1, P ¼ 0.031) and control (14.1 6
0.53 mm1, P ¼ 0.035) participants. However, there was no
significant difference among the groups in whole-image VD,
optic nerve VD, total peripapillary VD, and inferior peripap-
illary VD (P > 0.09).
The structural OCT measurements including the foveal,
RNFL, and GCC thickness in the MA, MO, and HC participants
are shown in Table 4. The MA participants demonstrated
borderline thinner average RNFL (97 6 1.8 lm) when
compared with the HC participants (104 6 2.1 lm, P ¼
0.05). In addition, the superior RNFL was marginally thinner in
the MA participants (116 6 2.4 lm) when compared with the
HC participants (127 6 3.9, P ¼ 0.049). There was no
significant difference among the groups in the thickness of
other quadrants of the RNFL (P > 0.08). In addition, there was
no significant difference among the groups in foveal (P > 0.43)
or GCC (P > 0.22) thickness.
Subgroup analysis by gender showed that female MA
participants had an enlarged FAZ area when compared with
the female MO participants (0.346 vs. 0.224 mm2, P ¼ 0.017)
FIGURE 3. Processing of optic nerve OCTA scans for measurement of whole-image VD, ONH VD, and peripapillary VD. The ONH segment (A) was
used for assessment of the whole image and ONH VD. After the raw image was made binary and skeletonized (B), the scanning laser
ophthalmoscopy (SLO) image was superimposed on the skeletonized image to trace the borders of the ONH (C). The area within the ONH borders
was used to assess ONH VD (D). The RPC segment was used to assess peripapillary VD (E). The raw image was similarly made binary and
skeletonized (F), and the SLO image was used to trace the borders of the ONH (G). A ring 0.5 mm in width around the ONH was selected, and the
peripapillary VD was assessed within this ring (H).
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and female HC participants (0.346 vs. 0.204 mm2, P¼ 0.012).
In addition, the female MA participants had decreased
superficial foveal VD when compared with the female HC
participants (7.3 vs. 10.4 mm1, P ¼ 0.002). There were no
significant differences on macular OCTA between the female
MO patients and the female HC participants (P > 0.33). There
were also no significant differences in macular OCTA measures
among male participants in the MA, MO, and HC groups (P >
0.07). Decreased superior peripapillary VD by OCTA of the
optic nerve was found in both the female and male MA
participants (P < 0.04).
DISCUSSION
We demonstrated by OCTA that MA, but not MO, patients had a
significantly enlarged FAZ area and reduced superficial foveal
VD when compared with the HC participants. In addition,
FIGURE 4. Representative macular OCTA scans of MA, MO, and HC participants. The FAZ area is shaded yellow in the top row. In the bottom row,
the skeletonized OCTA images of the SCP were used for the assessment of foveal VD within the outlined 13 1 mm circular area. Qualitatively, the
FAZ area is enlarged and foveal VD decreased in the MA participant when compared with the MO and HC participants.
FIGURE 5. Representative skeletonized OCTA scans of the optic nerve, segmented on the ONH in the top row and the RPC in the bottom row, in
eyes of MA, MO, and HC participants. The ellipses in the top row outline the borders of the ONH. In the bottom row, the inner ellipse demarcates
the ONH border, and the larger ellipse shows the outer border of the ring used to assess peripapillary VD. Qualitatively, the peripapillary VD is lower
in the MA participant when compared with the MO and HC participants.
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optic nerve OCTA showed that MA, but not MO, participants
had significantly decreased superior peripapillary VD.
The increased FAZ area found in the MA participants
suggests the possibility of a microangiopathy affecting the
retina. This is important in light of possible systemic vascular
risks of migraine with aura, including stroke and cardiovascular
disease.10,11 The enlargement of the FAZ area may be a result of
microvascular ischemic events or capillary remodeling adja-
cent to the normal FAZ, as has been suggested in other
systemic disorders such as diabetes25,26 and sickle cell
disease.27,28 Because this is a cross-sectional study, it is unclear
whether the FAZ changes are the result of ischemia in the
context of acute migrainous attacks or a systemic vasculopathy
that predisposes to both retinal microvascular alterations and
migraine with aura.
The finding of decreased foveal vessel density in the SCP in
the MA participants is also supportive of retinal microvascular
disease. Although we did not find a significant difference in the
DCP, there was a trend toward lower foveal VD in the MA
group. Assessment of VD in the DCP is hindered by projection
artifact, which is caused by the shadow of superficial blood
vessels projecting onto deeper layers.23 This artifact may have
contributed to the inability to detect a significant difference in
the DCP; alternatively, the sample size may have been
insufficient, as the power calculation was based on the
difference in FAZ area rather than VD among the groups.
The chronic retinovascular alterations demonstrated by
OCTA in the MA participants may be related to the increased
risk of ocular complications in migraine patients, even in the
absence of an acute attack. Greven et al.5 reported that 25% of
young adults with retinal arterial occlusions had a history of
migraines, and none were acutely symptomatic at the time of
the event. Furthermore, a history of migraine has been
reported in association with paracentral acute middle macu-
lopathy, an ischemic disorder of the middle and deep capillary
plexus in the macula.29
The finding of decreased peripapillary VD superiorly in the
MA patients has potential implications for optic nerve
disorders such as ischemic optic neuropathy and normal-
tension glaucoma. Both anterior and posterior ischemic optic
neuropathy have been reported in association with mi-
graines,8,9,13,14,30 and Arnold et al.15 found that a history of
migraine was a risk factor for non-arteritic anterior ischemic
optic neuropathy in patients younger than 50 years.
Migraine has also been associated with normal tension
glaucoma.17,18Among patients enrolled in the multicenter
randomized clinical trial, the Collaborative Normal Tension
Glaucoma Study, migraine was associated with an increased
risk of progression without treatment.17 The relative risk for
progression in migraine patients was 2.58, similar to that of
patients with disc hemorrhages (2.72). Our findings suggest
that the relationship between migraine and normal tension
glaucoma may be mediated by chronic reduction in peripap-
illary perfusion in the MA participants. OCTA studies in normal
tension glaucoma patients demonstrate decreased peripapil-
lary perfusion, and the amount of reduction correlates with
several measures of disease severity.31
By structural OCT, we found borderline decreased average
and superior RNFL thickness in MA, but not MO, participants
when compared with controls. This corresponds to the
superior peripapillary VD decrement demonstrated in MA
participants by OCTA. There were no differences in foveal or
GCC thickness. Given the relatively small absolute difference in
RNFL thickness between the groups (7 to 11 lm) and the
marginally significant P values (0.049 and 0.05), larger studies
are required to assess whether the RNFL is truly thinned in the
MA patients. Prior structural OCT studies in migraine patients
have shown conflicting results.32–38
By subgroup analysis, we found that the macular OCTA
differences in the MA participants were significant only in
females. This is consistent with the report that females with
migraine with aura have a higher risk of systemic ischemic
complications such as stroke.39 The pathophysiology of the
relationship between gender and ischemia in migraine is not
fully understood, but may be related to the effect of estrogen
and progesterone on endothelial cells.40
TABLE 2. Macular OCTA Measurements in MA, MO, and HC Participants
Macular OCTA Measures MA MO HC
Foveal avascular zone size, mm2 0.300 6 0.019 0.232 6 0.019 0.220 6 0.066, †P ¼ 0.006
SCP
Whole-image macular VD, mm1 15.3 6 0.47 15.9 6 0.39 15.8 6 0.32
Foveal VD, mm1 7.8 6 0.31 9.3 6 0.44, *P ¼ 0.04 9.4 6 0.21, †P ¼ 0.002
DCP
Whole-image macular VD, mm1 19.2 6 0.29 19.4 6 0.36 19.6 6 0.23
Foveal VD, mm1 7.9 6 0.34 8.8 6 0.54 8.1 6 0.30
All values indicate mean6 standard error of mean. Bold values indicate significance between groups (P < 0.05). SCP, superficial retinal capillary
plexus; DCP, deep retinal capillary plexus; VD, vessel density.
* P < 0.05, MA versus MO.
† P < 0.05, MA versus HC.
TABLE 3. OCTA Measurements in MA, MO, and HC Participants
Optic Nerve OCTA Measures MA MO HC
Whole-image VD, mm1 12.5 6 0.34 13.8 6 0.26 13.3 6 0.30
ONH VD, mm1 9.8 6 0.22 10.5 6 0.28 9.9 6 0.31
Peripapillary VD, mm1 12.2 6 0.41 13.6 6 0.34 13.4 6 0.33
Superior peripapillary VD, mm1 12.0 6 0.45 14.0 6 0.38, *P ¼ 0.031 14.1 6 0.53, †P ¼ 0.035
Inferior peripapillary VD, mm1 12.5 6 0.51 13.2 6 0.46 12.6 6 0.29
All values indicate mean 6 standard error of mean of VD in the area indicated. Bold values indicate significance between groups (P < 0.05).
ONH, optic nerve head.
* P < 0.05, MA versus MO.
† P < 0.05, MA versus HC.
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Our study has several limitations. The sample size was
relatively small—power analysis led us to the goal of recruiting
14 participants per group, and we successfully recruited more
than 14 MA and control participants, but only 12 MO
participants. Because this study was powered to assess the
primary outcome, the difference in FAZ area between the
groups, the study was underpowered to detect smaller
differences in other measures, especially when multiple
comparisons are considered. Future studies specifically de-
signed to assess measures other than FAZ area, such as optic
nerve OCTA and OCT changes in migraine, will require a larger
sample size.
We did not find significant differences in the DCP on
macular OCTA scans, and this may have been in part because
of the projection artifact, which introduces error in assessment
of the DCP. Recently, new software for projection artifact
removal has been developed that should improve the accuracy
of DCP measurements. However, we did not utilize this
software as it was not available at the time of image analysis
for this study. In addition, one macular OCTA and seven optic
nerve OCTA scans were excluded because of poor quality. This
represents only 7% of the total number of OCTA scans
performed, so we believe these missing scans were unlikely
to bias our results but cannot exclude this possibility. The
greater number of poor quality optic nerve OCTA scans may be
a result of the difficulty with eccentric fixation required to
image the optic nerve, or participant fatigue, as optic nerve
scans were always performed after macular scans in our study
protocol. Furthermore, although we excluded scans with
obvious segmentation failures (such as segmentation within
the vitreous cavity), we did not manually correct for subtle
errors of automatic segmentation as may occur, for example, in
eccentric scans with increased reflectivity of Henle’s fiber
layer.41 Finally, although our study protocol excluded normal
participants on medications with vasoactive effects, we did not
control for medications used by the MA and MO participants.
However, an equal percentage of patients in both groups (7 of
15 MA, and 6 of 12 MO) were taking triptans, which is a class
of migraine medications that has been associated with
vasoconstriction.39 This reduces but does not eliminate the
chance of medications confounding our comparison of MA and
MO participants.
In conclusion, we report enlarged FAZ area and decreased
VD in the superficial fovea and superior peripapillary region in
the eyes of MA, but not MO, participants when compared with
healthy controls. These findings may mediate the increased risk
of ocular complications such as retinovascular occlusion,
ischemic optic neuropathy, and normal tension glaucoma in
some patients with migraines. In addition, ocular perfusion
abnormalities may reflect vasculopathy in the cerebral or
systemic circulations. Further studies are necessary to deter-
mine whether OCTA findings in MA participants correlate with
a possible increased risk of ocular and systemic vascular
events. If such an association is found, OCTA could potentially
be useful as a fast, noninvasive, and relatively inexpensive
biomarker in patients with migraine with aura.
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